Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

Ulutas Med J. 2021; 7(4): 220-227


Serum Kallistatin Levels are Associated with the Pathogenesis of Sickle Cell Disease

Serdar Dogan, Hamza Malik Okuyan, Gul Ilhan.




Abstract
Cited by 0 Articles

Introduction: Sickle cell disease (SCD) is a prevalent monogenic hemoglobin disorder that presents a global burden with life-threatening complications. More studies are needed to understand the complex pathophysiology that causes multi-organ damage and develop effective approaches that ameliorate the clinical complications of patients with SCD. In the present study, we aimed to explore the relationship of Kallistatin with VEGF-A and TNF-α in patients with SCD.
Materials and methods: Thirty patients with SCD and 28 age- and sex-matched healthy subjects were included in the study. Serum Kallistatin, VEGF-A and TNF-α levels were measured by Enzyme-Linked Absorbent Assay (ELISA) and biochemical parameters were analyzed with routine techniques.
Results: The levels of Kallistatin, VEGF-A, leukocyte, AST, ALT, total bilirubin, direct bilirubin, LDH, and CRP were significantly higher in the patient group than in the control group whereas RBC and hemoglobin levels were significantly lower in patients than healthy individuals. Kallistatin levels were positively correlated with AST, total bilirubin, direct bilirubin, LDH, CRP, VEGF-A. VEGF-A levels were positively correlated with WBC, ALT, total bilirubin, while VEGF-A negatively correlated with RBC and hemoglobin. The areas under the receiver operating characteristic for Kallistatin and VEGF-A were 0.8536 and 0.7488, respectively.
Conclusion: We report for the first time that Kallistatin could be a novel marker associated with the pathogenesis of SCD.

Key words: Kallistatin, VEGF-A, Sickle Cell Disease, Angiogenesis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.